Rabaja, Ruben E.

HRN: 29-23-61  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/01/2026
07/08/2026
IVTT
1.5g
Q8H
Nonhealing Wound
Remove - Pending Acceptance
07/01/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/01/2026
07/08/2026
IVTT
600mg
Q8H
NONHEALING WOUND
Remove - Pending Acceptance
07/01/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/01/2026
07/08/2026
IV
600 Mg
Q6
Non-Healing Wound With Cellulitis, Right Leg
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: